The emerging approach of the medication represents a major development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide639609.bloggazza.com/40680394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment